BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 17436034)

  • 1. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
    Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
    Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is radiofrequency ablation safe for solitary kidneys?
    Jacobsohn KM; Ahrar K; Wood CG; Matin SF
    Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
    Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
    Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma.
    Nosnik IP; Mouraviev V; Nelson R; Polascik TJ
    Urology; 2006 Dec; 68(6):1343.e1-3. PubMed ID: 17141824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work.
    Watkins TW; Parkinson R
    Australas Radiol; 2007 Oct; 51(5):412-9. PubMed ID: 17803791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
    Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
    Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
    Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens.
    Park S; Strup SE; Saboorian H; Cadeddu JA
    Urology; 2006 Nov; 68(5):964-7. PubMed ID: 17113888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation of renal tumors in solitary kidney patients.
    Jiménez E; Zurera L; Espejo JJ; Requena MJ; Campos P; Rodríguez de Tembleque L; Canis M
    Arch Esp Urol; 2011; 64(1):51-8. PubMed ID: 21289386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined MRI and fluoroscopic guided radiofrequency ablation of a renal tumor.
    Fotiadis NI; Sabharwal T; Gangi A; Adam A
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):184-7. PubMed ID: 18392889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
    Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
    Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.
    Ukimura O; Kawauchi A; Fujito A; Mizutani Y; Okihara K; Mikami K; Soh J; Nakamura T; Nakanishi H; Ushijima S; Miki T
    Int J Urol; 2004 Dec; 11(12):1051-7. PubMed ID: 15663674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results.
    Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A
    Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
    Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
    BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.